Development and in vivo evaluation of a SARS-CoV-2 inactivated vaccine using high hydrostatic pressure

Development and in vivo evaluation of a SARS-CoV-2 inactivated vaccine using high hydrostatic pressure

Abstract Developing low-cost vaccine production strategies is crucial to achieving global health equity and mitigating the spread and impact of disease outbreaks. High hydrostatic pressure (HHP) technology is a widely used technology employed in the food industry for long-term preservation. This pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Martina Brandolini, Pietro Rocculi, Michele Morbarigazzi, Alessandra Mistral De Pascali, Giorgio Dirani, Silvia Zannoli, Davide Lelli, Antonio Lavazza, Francesca Battioni, Laura Grumiro, Simona Semprini, Massimiliano Guerra, Giulia Gatti, Laura Dionisi, Ludovica Ingletto, Claudia Colosimo, Anna Marzucco, Maria Sofia Montanari, Monica Cricca, Alessandra Scagliarini, Vittorio Sambri
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-025-01136-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41541-025-01136-7

Similar Items